To determine whether CCND2 is involved in the tumor progression and prognosis of lung cancer and breast cancer, CCND2 mRNA expression and clinical parameters of lung and breast cancer were analyzed in 760 breast cancer patients and 612 lung cancer patients from the TCGA datasets. Here, CCND2 is linked to breast carcinoma.